Zepbound
Enter your prices
Uses a 28-day refill interval.
Weight Loss
All Treatments
Resources
All Treatments
Weight Loss Treatments
Tirzepatide
Semaglutide
Wegovy Pill
Resources
Healthi App
Blog
Member Meetings
Recipes
Podcast
Patient Sign in
If you're choosing between Zepbound and HealthiCare's personalized Tirzepatide, the practical question is usually how you plan to pay. If insurance or the LillyDirect self-pay terms make Zepbound work for your budget, that path can fit well. If you're paying cash and want one predictable amount that covers the medication along with the clinical and personal care around it, HealthiCare is built for that.
If you're choosing between Zepbound and HealthiCare's personalized Tirzepatide, the practical question is usually how you plan to pay. If insurance or the LillyDirect self-pay terms make Zepbound work for your budget, that path can fit well. If you're paying cash and want one predictable amount that covers the medication along with the clinical and personal care around it, HealthiCare is built for that.
Both options use tirzepatide as the active ingredient. Zepbound is Eli Lilly's brand-name medication, approved by the FDA for its labeled uses. HealthiCare's personalized Tirzepatide is a cash-pay telehealth program where a licensed clinician reviews your intake, decides whether treatment is appropriate, and stays involved through ongoing care that is included in the monthly price.
Because the two are prepared differently, they are not interchangeable, and Zepbound's specific approval and trial results describe Zepbound rather than HealthiCare's preparation. The more useful question is which option actually fits your situation, and that is what the rest of this comparison is here to help you sort out.
Jump to the six-month cost calculator
| Comparison point | Zepbound | HealthiCare Personalized Tirzepatide |
|---|---|---|
| Active ingredient | Tirzepatide (dual GIP/GLP-1 receptor agonist) | Tirzepatide (dual GIP/GLP-1 receptor agonist) |
| Regulatory status | FDA-approved brand medication with reviewed label and manufacturing | Personalized preparation through HealthiCare's telehealth program, |
| What it treats | Long-term weight reduction and maintenance in specified adults, and moderate-to-severe obstructive sleep apnea in adults with obesity, alongside diet and activity | Long-term weight reduction and maintenance in specified adults, and moderate-to-severe obstructive sleep apnea in adults with obesity, alongside diet and activity |
| Dosing | Starts at 2.5 mg once weekly for four weeks as an initiation dose, not a maintenance dose. Maintenance depends on the indication. Maximum 15 mg weekly | Tirzepatide starts low (at 1.5mg) and increases slowly (to a max 13.5mg). Doses are titrated gradually so your body can adjust. This is by design — not a limitation. |
| How it's given | Subcutaneous injection through auto-injection pen, or self-administered through small insulin-style syringe. | Use small insulin-style syringe to draw the medication from a vial and self-administer subcutaneous injection. |
| Current cash price | LillyDirect self-pay: $299 for 2.5 mg and $399 for 5 mg. Doses of 7.5, 10, 12.5, and 15 mg are $449 through the Journey Program when the refill is purchased within 45 days of the previous delivery or receipt. Outside that 45-day window, regular prices are $499 for 7.5 mg and $699 for 10, 12.5, and 15 mg. 28-day supply | $224.40 per month on a quarterly treatment. No membership fees and every dose is the same price. |
| Insurance | May be lower with coverage or savings eligibility | Cash pay, with FSA and HSA eligibility |
Prices in this category change. Confirm current terms on the Zepbound prescribing information, the LillyDirect Zepbound page, the LillyDirect full terms and conditions, and the HealthiCare Tirzepatide page before you pay.
Use the cash prices you expect to pay. The calculator follows each option's billing interval so a 28-day refill is not treated as the same thing as a calendar-month charge.
Uses a 28-day refill interval.
Uses calendar-month billing.
This calculator adds the charges entered over six calendar months. It is not a quote and does not determine eligibility, treatment, dose, coverage, taxes, refunds, cancellation balances, or future prices. Confirm current terms before paying.
If HealthiCare sounds like a good fit, the next step is to go through a quick online intake. A licensed clinician reviews it and decides whether treatment is appropriate. Filling out the intake alone does not guarantee eligibility, a prescription, or a delivery date.
The best-known trial data for tirzepatide in weight management is SURMOUNT-1. It randomized 2,539 adults with a BMI of at least 30, or at least 27 with a weight-related complication, excluding people with diabetes. Participants received 5 mg, 10 mg, or 15 mg of tirzepatide, or placebo, once weekly for 72 weeks, including a 20-week dose escalation. Mean weight change at week 72 was minus 15.0%, minus 19.5%, and minus 20.9% across the three doses, compared with minus 3.1% for placebo.
Those numbers are group averages for the branded tirzepatide regimen studied in that population. They give you a reasonable sense of what tirzepatide at those doses produced on average. They are not a promise for any individual, and they are not product-specific evidence for HealthiCare's preparation.
The current Zepbound label carries a boxed warning about thyroid C-cell tumors observed in rats, with unknown relevance to humans. Zepbound is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in anyone who has had a serious hypersensitivity reaction to tirzepatide or to Zepbound excipients. The most common adverse reactions listed include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection-site reactions, fatigue, hypersensitivity reactions, belching, hair loss, and gastroesophageal reflux.
HealthiCare's program includes review by a licensed clinician to determine whether personalized Tirzepatide is appropriate for you. Because Zepbound's label applies specifically to Zepbound, its product-specific evidence and warnings should not be assumed to apply identically to other preparations. You can also review the FDA's information about unapproved GLP-1 drugs used for weight loss as part of an informed decision.
Switching between the two is easy and a smooth continuation of your treatment is important. When completing the HealthiCare intake form you will be prompted to share the details of your current Zepbound or GLP-1 treatment and dosage. Please provide all this information so your prescribing HealthiCare physician can prepare a Personalized Tirzepatide prescription that continues your current treatment.
The difference is not the medication itself, but how it’s produced and delivered. Brand-name products like Zepbound and Wegovy are mass-manufactured, patented versions sold in auto-injector pens. HealthiCare’s Personalized Tirzepatide medications are custom-prescribed by licensed physicians based on your individual needs. Patients typically experience the same clinical benefits when dosing and adherence are comparable. Many patients choose this option because it provides the same therapeutic effect at a significantly lower cost, with the added benefit of personalized dosing.
Yes! Making the switch is simple, and we want to help keep your treatment moving forward smoothly. When you complete the HealthiCare intake form, you’ll be asked about your current Zepbound or other GLP-1 medication and dosage. Please provide as much detail as possible so your HealthiCare physician can review your information and, if appropriate, prescribe a personalized tirzepatide treatment that supports a smooth transition.
No. A licensed clinician reviews your intake and decides whether treatment is appropriate. Intake does not guarantee eligibility, a prescription, or a delivery date.
HealthiCare's program is cash pay and is FSA and HSA eligible. It is not billed through medical insurance.
No! All doses are the same price. Your medication price within the program does not increase when the clinician changes your dose. Billing stays $264 monthly or $224.40 per month on a quarterly plan,, whichever plan you choose.
Predictable cash pricing includes the medication and clinical care, with no separate membership fee.
Start your weight loss journeyA licensed clinician reviews your intake. Completing it does not guarantee eligibility or a prescription.
This article provides general information and is not medical advice. Talk with a licensed clinician about whether tirzepatide, in any form, is appropriate for your individual health situation.
September 9, 2026
.avif)
